These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 9743961

  • 21. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL.
    J Clin Oncol; 2004 May 15; 22(10):1934-43. PubMed ID: 15143087
    [Abstract] [Full Text] [Related]

  • 22. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM, Ryder WD, Clemons MJ, Morgenstern GR, Chang J, Scarffe JH, Radford JA.
    Bone Marrow Transplant; 1999 Aug 15; 24(3):271-7. PubMed ID: 10455365
    [Abstract] [Full Text] [Related]

  • 23. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
    Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, Casasnovas O, Dupriez B, Souleau B, Taksin AL, Gisselbrecht C, Jaccard A, Omuro A, Sanson M, Janvier M, Kolb B, Zini JM, Leblond V, Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
    J Clin Oncol; 2008 May 20; 26(15):2512-8. PubMed ID: 18413641
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.
    Cairo MS, Krailo MD, Weinthal JA, Secola R, Bergeron S, van de Ven C, Blazar BR, Garrison L, Reaman GH.
    Cancer; 1998 Oct 01; 83(7):1449-60. PubMed ID: 9762948
    [Abstract] [Full Text] [Related]

  • 30. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein FG, Schulz A, Wawer A, Zintl F, Graf N.
    Bone Marrow Transplant; 2002 Dec 01; 30(12):893-8. PubMed ID: 12476282
    [Abstract] [Full Text] [Related]

  • 31. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.
    Kühl J, Müller HL, Berthold F, Kortmann RD, Deinlein F, Maass E, Graf N, Gnekow A, Scheurlen W, Göbel U, Wolff JE, Bamberg M, Kaatsch P, Kleihues P, Rating D, Sörensen N, Wiestler OD.
    Klin Padiatr; 1998 Dec 01; 210(4):227-33. PubMed ID: 9743957
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
    Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, Rademaker A, Marymount M, Kalapurakal J, Haut PR, Duerst R, Kletzel M.
    J Clin Oncol; 2004 Jul 15; 22(14):2885-90. PubMed ID: 15254057
    [Abstract] [Full Text] [Related]

  • 35. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
    Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.
    Biol Blood Marrow Transplant; 2005 Nov 15; 11(11):903-11. PubMed ID: 16275593
    [Abstract] [Full Text] [Related]

  • 36. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C.
    Bull Cancer; 1997 Mar 15; 84(3):264-72. PubMed ID: 9207872
    [Abstract] [Full Text] [Related]

  • 37. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.
    Biol Blood Marrow Transplant; 2006 Oct 15; 12(10):1085-91. PubMed ID: 17084372
    [Abstract] [Full Text] [Related]

  • 38. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Bajorin DF, Lara PN, Einhorn L, Mazumdar M, Bosl GJ.
    J Clin Oncol; 2007 Jan 20; 25(3):247-56. PubMed ID: 17235042
    [Abstract] [Full Text] [Related]

  • 39. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R, Guardia R, Altés A, Sureda A, Brunet S, Sierra J.
    Haematologica; 1999 Mar 20; 84(3):226-30. PubMed ID: 10189387
    [Abstract] [Full Text] [Related]

  • 40. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb 20; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.